It is now well accepted that there is a close relationship between noradrenergic and dopaminergic neurons in the brain, especially referring to the modulation of the locus coeruleus–norepinephrine (LC-NE) system on dopamine transmission. The disturbance of this modulation may contribute to neurodegeneration of dopaminergic neurons in Parkinson’s disease. In this article, we briefly review evidence related to such modulation. Firstly, we illustrated the noradrenergic innervation and functional implication for the LC-NE system and nigra–striatum dopaminergic system. Furthermore, we depicted neuroprotective effects of the LC-NE on dopaminergic neurons in vivo and in vitro. Moreover, we present data implicating the potential mechanisms underlying the modulation of the LC-NE system on dopaminergic neurons, in particular the effects of NE as a neurotrophic factor and through its ability to stimulate the expression of other neurotrophic factors, such as the brain-derived neurotrophic factor. Finally, we discussed other mechanisms intrinsic to NE’s effects. A better understanding of the noradrenergic modulation on dopaminergic neurons may be rewarding by significant advances in etiologic study and promising treatment of Parkinson’s disease.

FFifteen to thirty-five percent of the population in the United States experience tinnitus, a subjective "ringing in the ears". Up to 10% of tinnitus patients report their symptoms are severe and disabling. Tinnitus was induced in FBN rats using 116 dB (SPL) unilateral octave-band sound exposures centered at 16 kHz for one hour in an anesthetized preparation. Rats were assessed behaviorally by an operant conditioning paradigm as well as a gap detection method to verify the development of tinnitus. Both young (7 mos.) and aged (30 mos.) sound exposed rats showed significant elevated auditory brainstem-evoked response (ABR) thresholds for clix and all tested frequencies immediately after the sound exposure. Eighty days post-exposure, ABR thresholds for the young exposed rats were significantly close to the initial young control values while aged exposed rats showed residual thresholds shifts relative to aged controls. Sixteen weeks following sound exposure, young exposed rats showed significantly reduced gap detection at 24 and 32 kHz, suggestive of high frequency tinnitus. Aged exposed animals showed significant tinnitus-related behavioral changes near 10 kHz by both behavior methods. Message and protein levels of &alpha1-3 glycine receptor subunits (GlyRs), gephyrin, BDNF and its receptor TrkB were assessed in dorsal cochlear nucleus (DCN) fusiform cells 4 months post exposure utilizing quantitative in situ hybridization and immunocytochemistry. Young exposed rats showed significant decreases of GlyR &alpha1 protein at middle and high frequency regions in DCN unlike the contrasting increase of their message levels. Aged exposed rats showed higher &alpha1 subunit protein levels in the same high and middle DCN frequency regions. The GlyR anchoring protein, gephyrin, was significantly increased in both young and aged exposed rats, suggesting an intracellular receptor trafficking change following acoustic trauma. BDNF and TrkB were also increased over fusiform cells in both young and aged exposed rats. [3H] strychnine binding was used to evaluate DCN GlyR pharmacology and function following sound exposure. The age-related decrease in GlyR α1 protein was reflected in the significant age-related down-regulation of GlyR (Bmax). Tinnitus-related changes in GlyR &alpha1 protein level was reflected in the decline of the GlyR (Bmax) in young exposed rats and up-regulated GlyRs in aged exposed animals. The GlyRs in DCN of young exposed animals also demonstrated an increase in affinity, further suggesting a post-exposure receptor composition change. These findings suggest that both aging and/or sound exposure/tinnitus are associated with GlyR changes capable of altering alter the output of the DCN. Detailed characterization of these GlyR modifications could advance the development of novel selective drugs for tinnitus and age-related hearing loss.

This study evaluated the effects of chronic olanzapine treatment on cognitive performance and neurochemical function in a rodent model of schizophrenia. Animals were neonatally treated with quinpirole, a dopamine D2 receptor agonist, or saline. Quinpirole treatment produces an increase of dopamine D2 receptor sensitivity that extends into adulthood, known as D2 receptor priming, similar to a phenomenon that occurs in schizophrenia. These same rats were treated in adulthood for 28 days with olanzapine, an atypical antipsychotic, or saline. Dopamine D2- primed rats demonstrated significant deficits on a cognitive task that were alleviated by olanzapine treatment. Brain tissue analysis revealed that D2-primed animals demonstrated a significant decrease in the neurotrophins nerve growth factor (NGF) in the hippocampus and brain-derived neurotrophic factor (BDNF) in the frontal cortex. Olanzapine treatment alleviated the decrease in NGF. The results suggest that olanzapine eliminates cognitive impairment and may have neuroprotective properties in the hippocampus of D2-primed rats.

Aging and Alzheimer’s disease (AD) are associated with decreased cognitive function and neural degeneration. The basal forebrain is one of the first areas of the brain to degenerate in AD and depends on the neurotrophin brain-derived neurotrophic factor (BDNF) for survival. Loss of BDNF transport from target neurons may contribute to basal forebrain cholinergic neuron (BFCN) vulnerability in AD and aging. Oxidative stress is associated with cholinergic dysfunction and cognitive decline in aging and AD, and it is possible that oxidative stress may contribute to BDNF transport deficits in BFCNs. BFCNs are grown in microfluidic chambers that allow isolation of BFCN soma and axon terminals so transport of biotinylated and fluorescently labelled BDNF can be quantified. The objective of my research was to determine if oxidative stress induces BDNF retrograde transport deficits in BFCNs, and the mechanism behind this effect. I found that oxidative stress does reduce BDNF retrograde transport in BFCNs. Because it has previously been shown that aged BFCNs have decreased BDNF transport and downregulate the BDNF receptor TrkB, expression of both TrkB and p75NTR receptors was tested following oxidative stress using immunocytochemistry (ICC) and western blotting. This experiment showed that oxidative stress does not affect p75NTR or TrkB receptor levels. A likely alternative is that oxidative stress may lead to alterations in the transport machinery responsible for retrograde BDNF transport. I hypothesized that oxidative stress decreases retrograde axonal transport of BDNF via increased insulin-like growth factor 1 receptor (IGF1R) activity, which decreases the protein expression of the adaptor proteins BICD1 and Hook1 by inhibiting GSK3β activity via the PI3K-Akt pathway. ICC and western blotting showed that oxidative stress has no effect on either BICD1 or Hook1 levels. Future directions of this work involve further studying the involvement of the IGF1R pathway in oxidative stress, and the effect on other proteins involved in BDNF transport, including htt and DISC1. / Thesis / Master of Science (MSc)

No description available.

Background: Suicide is a worldwide concern, claiming nearly one million lives each year. The causes of suicidal behaviour are unclear, but a variety of biological, psychological, social, and environmental factors are thought to contribute to suicide risk. Many cases of suicidal behaviour cannot be explained by conventional risk proposed by clinical and research observations. Recent research has focused on biomarkers of suicidal behaviour, including brain-derived neurotrophic factor (BDNF). This thesis aims to determine the association between BDNF and suicidal behaviour by reviewing the literature and by analyzing clinical data. An additional aim of this thesis is to explore the associations between social factors and suicidal behaviour, with a particular focus on sex differences within these factors. Methods: We explored the associations between biological and social risk factors and suicidal behaviour in several ways. We conducted a systematic review to summarize and evaluate the literature regarding BDNF levels and suicidal behaviour. The protocol for this systematic review was designed and published a priori. We performed a qualitative review of the literature and a meta-analysis of studies of serum BDNF and attempted suicide. Then, we assessed the association between serum BDNF and attempted suicide using a case-control study design. We analyzed data collected from the Study of Determinants of Suicide Conventional and Emergent Risk (DISCOVER), and age- and sex-matched study of attempted suicide. In a sample of 250 participants (84 cases of attempted suicide, 104 psychiatric controls, and 93 community controls), we used linear regression analysis to determine the association between BDNF level and attempted suicide, adjusting for age, sex, body mass index, current smoking status, and antidepressant use. Finally, using the same dataset, we explored the associations of a number of social factors with attempted suicide. In a sample of 343 participants (146 cases, 104 psychiatric controls, and 93 community controls), we used logistic regression analyses to determine the associations between social risk factors and attempted suicide in men and women separately. These included age, education level, employment status, marital status, religious practice, stressful life events, and childhood abuse. Results: Our systematic review included 14 studies. The meta-analysis of three studies of serum BDNF and attempted suicide showed no significant association. The qualitative review of all studies revealed inconsistent findings regarding associations between BDNF and suicidal behaviour. In our study of serum BDNF and attempted suicide in the DISCOVER dataset, attempted suicide was not significantly associated with BDNF level. In our study of social factors for attempted suicide, some sex differences were found: Completion of post-secondary education and religious practice were found to be significant protective factors against attempted suicide only in women, and unemployment and stressful life events were significant risk factors only in men. Conclusion: This thesis provides important findings about the biological and social risk factors for suicidal behaviour. Understanding the determinants of suicidal behaviour can aid clinicians in identifying and treating vulnerable individuals. / Thesis / Master of Science (MSc)

Epilepsy is a neurological disorder that causes recurrent and unprovoked seizures due to imbalances in synaptic transmission in distinct regions of the brain. In both human patients and animal models of epilepsy, there is a marked increase in brain-derived neurotrophic factor (BDNF), a critical signaling molecule in the brain that contributes to two divergent pathways important to disease pathology: 1) the regulation of type A receptors for the major inhibitory neurotransmitter GABA (GABAARs), and 2) aberrant neurogenesis with ectopic expression of new neurons from progenitor cells that disrupt neural network activity in the hippocampus. The first part of my thesis addresses how neurons regulate levels of α1-containing GABAARs through BDNF signaling at its receptors, tropomyosin receptor kinase B (TrkB) and p75 neurotrophin receptor (p75NTR). I hypothesized and showed that BDNF, working at TrkB, rapidly activates the Janus kinase and signal transducers and activators of transcription (JAK/STAT) pathway in neurons and identified a novel intracellular receptor signaling complex composed of p75NTR and JAK2 that is present in neuronal processes, cell body, and nucleus. Based on this finding, we suggest that an intracellular p75NTR/JAK2 signalsome recruits STAT3, a transcriptional activator of the gene coding for the cAMP inducible early repressor (ICER) that blocks synthesis of α1 subunits reducing synaptic GABAARs in response to status epilepticus. This model is consistent with our collaborative studies that show a JAK2 inhibitor, WP1066, inhibits development of spontaneous seizures in an epilepsy model and my observation that WP1066 degrades JAK2 protein in primary neurons. The second part of my thesis addresses BDNF regulation of the Late SV40 Factor (LSF), a ubiquitous transcription factor that regulates cell cycle progression and survival. I show that BDNF through the mitogen-activated protein kinase pathway selectively phosphorylates LSF at serine 291 (p291LSF) and that p291LSF is present throughout neurogenesis, increases with status epilepticus in the hippocampus, and is highest in structures associated with neurogenesis (such as olfactory bulb and hippocampus when compared to cortex). Taken together, these results suggest LSF may play an important role in neuronal development and potentially in epilepsy, providing an additional target for future therapeutic intervention. / 2016-12-15T00:00:00Z

No description available.

Nicotine addiction continues to be a leading cause of preventable death worldwide. Despite the plethora of available treatments for smoking cessation, smoking relapse after attempts to quit remains high. It is possible that impairments in cognitive flexibility and underlying neurochemical circuits in nicotine addicts may foster maladaptive behaviors that affect individuals’ ability to refrain from taking drugs. Here we characterized the effects of spontaneous nicotine withdrawal on cognitive flexibility in mice using an operant strategy set-shifting task. Because frontostriatal circuits are critical for cognitive flexibility and brain-derived neurotrophic factor (BDNF) modulates glutamate plasticity, we also explored the effects of nicotine withdrawal on these neurochemical substrates. Adult male C57BL/6J mice were trained in an operant task that required the animals to switch from using a spatial response-driven strategy to a visual cue-based strategy to achieve rewards. Mice were exp / Psychology

Yes / The photoperiod is the main environmental cue that drives seasonal adaptive responses in reproduction, behavior, and metabolism in seasonal animals. Increasing evidence suggests that (poly)phenols contained in fruits can also modulate seasonal rhythms. (Poly)phenol-rich diets are associated with an improvement in cognitive function and neuroprotection due to their anti-inflammatory and antioxidative properties. However, it is unknown whether cherries affect neuroprotection in a photoperiod-dependent manner. To test this, F344 rats were exposed to L6 (6 h light/day), L12 (12 h light/day) and L18 (18 h light/day) photoperiods and fed a standard chow diet supplemented with either a control, lyophilized cherry 1 or cherry 2 with distinctive phenolic hallmarks. Physiological parameters (body weight, eating pattern index (EPI), testosterone, T4/T3) and hypothalamic key genes (Dio2, Dio3, Raldh1 and Ghrh) were strongly regulated by the photoperiod and/or fruit consumption. Importantly, we show for the first time that neurotrophs (Bdnf, Sod1 and Gpx1) in the hippocampus are also regulated by the photoperiod. Furthermore, the consumption of cherry 2, which was richer in total flavonols, but not cherry 1, which was richer in total anthocyanins and flavanols, enhanced neuroprotection in the hippocampus. Our results show that the seasonal consumption of cherry with a specific phenolic composition plays an important role in the hippocampal activation of neuroprotection in a photoperiod-dependent manner. / This work was supported by grant number PID2020-113739RB-I00 funded by MCIN/AEI/10.13039/501100011033 and by Pect-Nutrisalt funded by the European Regional Development Fund of the European Commission through the Operative Program Erdf of Catalonia 2014–2020. The authors thank the British Society for Neuroendocrinology (BSN) for providing a research visit Grant to F.M (Grant number: BSN-2022-1452). F.M. is the recipient of a predoctoral fellowship from Universitat Rovira i Virgili—Martí i Franquès (Grant number: 2019PMF-PIPF-19).